The solubility of Atglistatin is validated at a concentration of 20 mg/mL in DMSO yielding a clear solution. Further dilutions into aqueous solutions, such as cell culture media or PBS, are not validated and would have to be evaluated by the end-user.
Fortfahren mit
SML1075
Atglistatin
≥98% (HPLC), powder, adipose triglyceride lipase inhibitor
Synonym(e):
3-(4′-(Dimethylamino)-[1,1′-biphenyl]-3-yl)-1,1-dimethylurea
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
5 mg | Warenkorb auf Verfügbarkeit prüfen | € 128,00 |
25 mg | Warenkorb auf Verfügbarkeit prüfen | € 506,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C17H21N3O
CAS-Nummer:
Molekulargewicht:
283.37
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
Atglistatin, ≥98% (HPLC)
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
2-8°C
SMILES string
CN(C)C(NC1=CC=CC(C2=CC=C(N(C)C)C=C2)=C1)=O
InChI
1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)
InChI key
AWOPBSAJHCUSAS-UHFFFAOYSA-N
Application
Biochem/physiol Actions
Atglistatin is a selective inhibitor of adipose triglyceride lipase (ATGL).
Atglistatin is the first selective inhibitor of adipose triglyceride lipase (ATGL), the rate limiting enzyme involved in the mobilization of fatty acids from cellular triglyceride stores. Atglistatin has an IC50 of 0.7 μM in E.coli and no activity against monoglycerol lipase (MGL), hormone-sensitive lipase (HSL), or pancreatic lipase and lipoprotein lipase PNPLA6 and PNPLA7. ATGL generates diacylglycerol from cellular triglyceride stores, which is then degraded by hormone-sensitive lipase (HSL) and monoglyceride lipase into glycerol and fatty acids, promoting the synthesis of lipotoxic metabolites that have been associated with the development of insulin resistance. Atglistatin inhibition of ATGL has been shown to reduce fatty acid mobilization in vitro and in vivo.
Other Notes
Produced under the license of University of Graz/Graz University of Technolog
Still not finding the right product?
Explore all of our products under Atglistatin
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
Can cell media/PBS be used as a diluent for stock solutions of Atglistatin for an in-vitro treatment paradigm?
1 answer-
Helpful?
-
-
How long do stock and working solutions of ATGListatin last when stored in 2-8*C?
1 answer-
The stability of stock solutions at 2-8°C has not been determined. Following reconstitution, solutions in DMSO may be aliquoted and frozen at -20°C for up to 6 months. Various external sources indicate stock solutions prepared in Ethanol may be stored at -20°C for up to 3 months. This information has not been validated.
Helpful?
-